Association Between Homocysteine and Type 2 Diabetes Mellitus: a Systematic Review and Meta-analysis
Association Between Homocysteine and Type 2 Diabetes Mellitus: a Systematic Review and Meta-analysis
复制标题
同型半胱氨酸与 2 型糖尿病之间的关联:系统评价和荟萃分析
DOI:
10.1007/s13410-021-00933-9
复制
发表时间:
2021-02
影响因子:
0.9
通讯作者:
Lanqing Ma
中科院分区:
文献类型:
--
作者:
Jinxiang Wang;Dingyun You;Huaping Wang;Chenggang Zou;Yanhong Yang;Dan Zhang;Mingke Li;Chunmei Li;Junyan Lv;Sufeng Luo;Xue Yu;Rui Liao;Lanqing Ma
BackgroundSeveral studies have been performed to assess the relationship between hyperhomocysteinemia and type 2 diabetes mellitus (T2DM). However, inconsistent results have been obtained. Therefore, we performed this meta-analysis to address this knowledge gap.MethodsWe searched PubMed, Cochrane library, and EMBASE database for studies that evaluated the relationship between blood homocysteine (HCY) level and T2DM from inception to Jun 2019. The quality of all included studies was assessed by the Newcastle Ottawa Scale (NOS) and the Agency for Healthcare Research Quality (AHRQ). RevMan5.3 and Stata12.0 were used for data analyses.ResultsTwenty-five studies (including 1881 cases and 2868 controls) on blood HCY level in T2DM were pooled in our meta-analysis. The blood HCY level in the T2DM patients was significantly higher than in the healthy individuals (SMD = 0.63, 95% CI = 0.43–0.84, andp< 0.001,I2= 89%,p< 0.001), ignores the effects of age, sex, cardiovascular and cerebrovascular disease conditions, and other comorbidity. Additionally, in T2DM patients with nephropathy or retinopathy, blood HCY level was also significantly higher than in those with only T2DM (SMD = 1.17, 95% CI = 0.76–1.58,p< 0.001;I2= 90%,p< 0.001 and SMD = 0.91, 95% CI = 0.39–1.44,p <0.001;I2= 82%,p <0.001, respectively).ConclusionOur meta-analysis revealed the HCY level in the blood of T2DM patients was significantly higher than those of the health subjects, especially in patients with diabetic nephropathy (DN) and diabetic retinopathy (DR).
登录
查看更多内容
影响因子:
3
作者:
S. Das;Tammy Reynolds;A. Patnaik;N. Rais;L. Fink;V. Fonseca
通讯作者:
S. Das;Tammy Reynolds;A. Patnaik;N. Rais;L. Fink;V. Fonseca
影响因子:
5.1
作者:
Guariguata, L.;Whiting, D. R.;Shaw, J. E.
通讯作者:
Shaw, J. E.
DOI:
10.1136/bmj.b2535
发表时间:
2009-07-21
期刊:
BMJ (Clinical research ed.)
影响因子:
--
作者:
Moher D;Liberati A;Tetzlaff J;Altman DG;PRISMA Group
通讯作者:
PRISMA Group
影响因子:
5.3
作者:
Sofi, Francesco;Marcucci, Rossella;Prisco, Domenico
通讯作者:
Prisco, Domenico
影响因子:
16.2
作者:
Aso, Y;Okumura, K;Inukai, T
通讯作者:
Inukai, T